We propose that this mechanism may account for maintained prostate cancer cell growth through concerted activity with the AR in HES6-driven androgen insensitivity, where the AR persistently binds to chromatin at a subset of binding sites and seems to be essential for the survival of the resistant cells, which cannot withstand AR knock-down. This evidence concerns the gene AR and prostate carcinoma.